Table 5.
Control | SDP | sem | P | |
---|---|---|---|---|
0 h – immediately after birth* | ||||
PEPT1 | 1·68 | 1·86 | 0·25 | 0·626 |
FABP2 | 0·97 | 1·12 | 0·25 | 0·676 |
SGLT1 | 0·92 | 0·74 | 0·10 | 0·253 |
GLUT1 | 1·41 | 0·99 | 0·25 | 0·255 |
GLUT2 | 1·97 | 1·71 | 0·38 | 0·646 |
48 h after birth* | ||||
PEPT1 | 1·79 | 2·00 | 0·27 | 0·593 |
FABP2 | 1·12 | 1·27 | 0·30 | 0·732 |
SGLT1 | 1·12 | 0·80 | 0·11 | 0·050 |
GLUT1 | 1·73 | 1·38 | 0·38 | 0·536 |
GLUT2 | 2·18 | 1·78 | 0·40 | 0·501 |
Weaning* | ||||
PEPT1 | 1·71 | 0·43 | 0·35 | 0·025 |
FABP2 | 1·78 | 2·05 | 0·65 | 0·783 |
SGLT1 | 1·42 | 2·23 | 0·44 | 0·226 |
GLUT1 | 0·98 | 0·65 | 0·06 | 0·003 |
GLUT2 | 1·76 | 0·41 | 0·36 | 0·025 |
SDP, seaweed-derived polysaccharides containing laminarin and fucoidan; PEPT, peptide transporter; FABP, fatty acid binding protein; SGLT, sodium–glucose-linked transporter; GLUT, glucose transporter.
n 8 piglets per treatment group.